Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11935)
All Articles published online
|
Publishing Process of This Article
|
Mar 6, 2016 (publication date) through May 10, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Nephrology
ISSN
2220-6124
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | William JH, Danziger J. Proton-pump inhibitor-induced hypomagnesemia: Current research and proposed mechanisms. World J Nephrol 2016; 5(2): 152-157 [PMID: 26981439 DOI: 10.5527/wjn.v5.i2.152] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v5/i2/152.htm |
| Number | Citing Articles |
| 1 |
Mary R. Rooney, Elizabeth J. Bell, Alvaro Alonso, James S. Pankow, Ryan T. Demmer, Kyle D. Rudser, Lin Y. Chen, Pamela L. Lutsey. Proton Pump Inhibitor Use, Hypomagnesemia and Risk of Cardiovascular Diseases. Journal of Clinical Gastroenterology 2021; 55(8): 677 doi: 10.1097/MCG.0000000000001420
|
| 2 |
Mehmet UZUNLULU, Elif PALA, Aysu TANRİVERMİS, Muhammed Mikdat AKBAS, Ender İĞNECİ, Miraç VURAL KESKİNLER. Why Magnesium Level Check Should be Part of Standard Diabetes Care?. DAHUDER Medical Journal 2024; 4(1): 28 doi: 10.56016/dahudermj.1408723
|
| 3 |
Evan Elias, Laura E. Targownik. The Clinician’s Guide to Proton Pump Inhibitor Related Adverse Events. Drugs 2019; 79(7): 715 doi: 10.1007/s40265-019-01110-3
|
| 4 |
Decio CHINZON, Gerson DOMINGUES, Nivia TOSETTO, Marcos PERROTTI. SAFETY OF LONG-TERM PROTON PUMP INHIBITORS: FACTS AND MYTHS. Arquivos de Gastroenterologia 2022; 59(2): 219 doi: 10.1590/s0004-2803.202202000-40
|
| 5 |
Masayuki Aiba, Yutaka Tsutsumi, Jun Nagai, Takahiro Tateno, Shinichi Ito. Convulsive Seizure Due to Hypomagnesemia Caused by Short-term Vonoprazan Intake. Internal Medicine 2022; 61(2): 237 doi: 10.2169/internalmedicine.7758-21
|
| 6 |
Mitchell H. Rosner, Nam Ha, Biff F. Palmer, Mark A. Perazella. Acquired Disorders of Hypomagnesemia. Mayo Clinic Proceedings 2023; 98(4): 581 doi: 10.1016/j.mayocp.2022.12.002
|
| 7 |
Bent-Are Hansen, Øyvind Bruserud. Hypomagnesemia as a potentially life-threatening adverse effect of omeprazole. Oxford Medical Case Reports 2016; 2016(7): 147 doi: 10.1093/omcr/omw062
|
| 8 |
Rawa Bapir, Kamran Hassan Bhatti, Ahmed Eliwa, Herney Andrés García-Perdomo, Nazim Gherabi, Derek Hennessey, Vittorio Magri, Panagiotis Mourmouris, Adama Ouattara, Gianpaolo Perletti, Joseph Philipraj, Konstantinos Stamatiou, Musliu Adetola Tolani, Lazaros Tzelves, Alberto Trinchieri, Noor Buchholz. Risk of urinary stone formation associated to proton pump inhibitors: A systematic review and metanalysis. Archivio Italiano di Urologia e Andrologia 2022; 94(4): 507 doi: 10.4081/aiua.2022.4.507
|
| 9 |
Yehia Y Mishriki. PPI-induced hypomagnesemia with secondary hypoparathyroidism and posterior reversible encephalopathy syndrome restricted to the cerebellum. Case Reports International 2020; 9(2): 1 doi: 10.5348/100085Z06YM2020CR
|
| 10 |
Naohi Isse, Masashi Hashimoto. Republished: Omeprazole-induced hypomagnesaemia, causing renal tubular acidosis with hypokalaemia, hypocalcaemia, hyperlactacidaemia and hyperammonaemia. Drug and Therapeutics Bulletin 2021; 59(4): 60 doi: 10.1136/dtb.2021.235385rep
|
| 11 |
Abdullah M. Al Alawi, Sandawana William Majoni, Henrik Falhammar. Magnesium and Human Health: Perspectives and Research Directions. International Journal of Endocrinology 2018; 2018: 1 doi: 10.1155/2018/9041694
|
| 12 |
Synne Semb, Frederik Helgstrand, Flemming Hjørne, Peter Bytzer. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication. World Journal of Gastroenterology 2017; 23(37): 6907-6910 doi: 10.3748/wjg.v23.i37.6907
|
| 13 |
Geoffrey Cheminet, Gabrielle Clain, Anne-Sophie Jannot, Brigitte Ranque, Amélie Passeron, Adrien Michon, Gonzalo De Luna, Jean-Luc Diehl, Stéphane Oudard, Christophe Cellier, Alexandre Karras, Benoit Vedié, Caroline Prot-Bertoye, Jacques Pouchot, Jean-Benoît Arlet. Extreme hypomagnesemia: characteristics of 119 consecutive inpatients. Internal and Emergency Medicine 2018; 13(8): 1201 doi: 10.1007/s11739-018-1898-7
|
| 14 |
Xiaohao Wang, Zhaohao Zeng, Xinyu Wang, Pengfei Zhao, Lijiao Xiong, Tingfeng Liao, Runzhu Yuan, Shu Yang, Lin Kang, Zhen Liang. Magnesium Depletion Score and Metabolic Syndrome in US Adults: Analysis of NHANES 2003 to 2018. The Journal of Clinical Endocrinology & Metabolism 2024; doi: 10.1210/clinem/dgae075
|
| 15 |
Javier A Villafuerte-Gálvez. Proton Pump Inhibitors and Incident Clostridioides difficile Infection: Beyond Controversy, Pragmatic Approaches Are Needed. Clinical Infectious Diseases 2021; 72(12): e1090 doi: 10.1093/cid/ciaa1856
|
| 16 |
Maria Salinas, Maite López-Garrigós, Emilio Flores, Carlos Leiva-Salinas. Improving diagnosis and treatment of hypomagnesemia. Clinical Chemistry and Laboratory Medicine (CCLM) 2024; 62(2): 234 doi: 10.1515/cclm-2023-0537
|
| 17 |
Lei Fan, Xiangzhu Zhu, Andrea Rosanoff, Rebecca B Costello, Chang Yu, Reid Ness, Douglas L Seidner, Harvey J Murff, Christianne L Roumie, Martha J Shrubsole, Qi Dai. Magnesium Depletion Score (MDS) Predicts Risk of Systemic Inflammation and Cardiovascular Mortality among US Adults. The Journal of Nutrition 2021; 151(8): 2226 doi: 10.1093/jn/nxab138
|
| 18 |
Liang Tian, Chongfei Huang, Wenkang Fu, Long Gao, Ningning Mi, Mingzhen Bai, Haidong Ma, Chao Zhang, Yawen Lu, Jinyu Zhao, Xianzhuo Zhang, Ningzu Jiang, Yanyan Lin, Ping Yue, Jinqiu Yuan, Wenbo Meng. Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1217306
|
| 19 |
Ryuichi Kambayashi, Ai Goto, Hiroko Izumi-Nakaseko, Yoshinori Takei, Atsushi Sugiyama. <i>In vivo</i> analysis of acute eletropharmacological effects of proton pump inhibitors using halothane-anesthetized dogs: a translational study of cardiovascular adverse events. The Journal of Toxicological Sciences 2023; 48(7): 375 doi: 10.2131/jts.48.375
|
| 20 |
Sneha Teresa Selvin, Sonu Thomas, Viktoriya Bikeyeva, Ahmed Abdullah, Aleksandra Radivojevic, Anas A Abu Jad, Anvesh Ravanavena, Chetna Ravindra, Emmanuelar O Igweonu-Nwakile, Safina Ali, Salomi Paul, Shreyas Yakkali, Prachi Balani. Establishing the Association Between Osteoporosis and Peptic Ulcer Disease: A Systematic Review. Cureus 2022; doi: 10.7759/cureus.27188
|
| 21 |
Amit Kumar Dutta, Abhinav Jain, Vaneet Jearth, Ramit Mahajan, Manas Kumar Panigrahi, Vishal Sharma, Mahesh Kumar Goenka, Rakesh Kochhar, Govind Makharia, Duvvur Nageshwar Reddy, Richard Kirubakaran, Vineet Ahuja, Neha Berry, Naresh Bhat, Usha Dutta, Uday Chand Ghoshal, Ajay Jain, Umesh Jalihal, V. Jayanthi, Ajay Kumar, Sandeep Nijhawan, Ujjal Poddar, G. N. Ramesh, Shivram P Singh, Showkat Zargar, Shobna Bhatia. Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship. Indian Journal of Gastroenterology 2023; 42(5): 601 doi: 10.1007/s12664-023-01428-7
|
| 22 |
George Liamis, Ewout J. Hoorn, Matilda Florentin, Haralampos Milionis. An overview of diagnosis and management of drug‐induced hypomagnesemia. Pharmacology Research & Perspectives 2021; 9(4) doi: 10.1002/prp2.829
|
| 23 |
Gheith Yousif. Critical Hypomagnesemia and Seizure Induced by Chronic Use of Proton Pump Inhibitors (PPIs). Translation: The University of Toledo Journal of Medical Sciences 2019; 6: 3 doi: 10.46570/utjms.vol6-2019-285
|
| 24 |
Naohi Isse, Masashi Hashimoto. Omeprazole-induced hypomagnesaemia, causing renal tubular acidosis with hypokalaemia, hypocalcaemia, hyperlactacidaemia and hyperammonaemia. BMJ Case Reports 2020; 13(7): e235385 doi: 10.1136/bcr-2020-235385
|
| 25 |
Hideyuki Katsura, Yukio Suga, Anna Kubo, Hayato Sugimura, Kaname Kumatani, Kazunobu Haruki, Miwa Yonezawa, Ayaka Narita, Rei Ishijima, Hiroaki Ikesue, Hitomi Toi, Naoko Takata. Risk Evaluation of Proton Pump Inhibitors for Panitumumab-Related Hypomagnesemia in Patients with Metastatic Colorectal Cancer. Biological and Pharmaceutical Bulletin 2024; 47(1): 98 doi: 10.1248/bpb.b23-00641
|
| 26 |
Łukasz Lassmann, Matteo Pollis, Agata Żółtowska, Daniele Manfredini. Gut Bless Your Pain—Roles of the Gut Microbiota, Sleep, and Melatonin in Chronic Orofacial Pain and Depression. Biomedicines 2022; 10(7): 1528 doi: 10.3390/biomedicines10071528
|
| 27 |
Eli D Ehrenpreis, George Jarrouj, Ryan Meader, Chris Wagner, Marie Ellis. A comprehensive review of hypomagnesemia. Disease-a-Month 2022; 68(2): 101285 doi: 10.1016/j.disamonth.2021.101285
|
| 28 |
Rui Qi Chong, Ingrid Gelissen, Betty Chaar, Jonathan Penm, Janet MY Cheung, Joanna E. Harnett. Do medicines commonly used by older adults impact their nutrient status?. Exploratory Research in Clinical and Social Pharmacy 2021; 3: 100067 doi: 10.1016/j.rcsop.2021.100067
|
| 29 |
Peter Fentz Haastrup, Wade Thompson, Jens Søndergaard, Dorte Ejg Jarbøl. Side Effects of Long‐Term Proton Pump Inhibitor Use: A Review. Basic & Clinical Pharmacology & Toxicology 2018; 123(2): 114 doi: 10.1111/bcpt.13023
|
| 30 |
Leo Monnens. Still a vigilant attitude required to prevent hypomagnesemia. Acta Paediatrica 2021; 110(5): 1690 doi: 10.1111/apa.15589
|
| 31 |
Emily Mohn, Hua Kern, Edward Saltzman, Susan Mitmesser, Diane McKay. Evidence of Drug–Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update. Pharmaceutics 2018; 10(1): 36 doi: 10.3390/pharmaceutics10010036
|
| 32 |
Marie Bagge Jensen, Jette Jakobsen, Charlotte Jacobsen, Jens J. Sloth, Jone Ibarruri, Carlos Bald, Bruno Iñarra, Niels Bøknæs, Ann-Dorit Moltke Sørensen. Content and Bioaccessibility of Minerals and Proteins in Fish-Bone Containing Side-Streams from Seafood Industries. Marine Drugs 2024; 22(4): 162 doi: 10.3390/md22040162
|
| 33 |
Carolyn Vera Coulter. The role of the suspicious renal pharmacist in identifying unusual adverse drug reactions—why this is not a small problem. International Journal of Clinical Pharmacy 2018; 40(4): 775 doi: 10.1007/s11096-018-0660-6
|
| 34 |
Stuart Jon Spechler. Proton Pump Inhibitors. Medical Clinics of North America 2019; 103(1): 1 doi: 10.1016/j.mcna.2018.08.001
|
| 35 |
Karim Kheir, Omar Al Jassem, Georgio El Koubayati, Fady Haddad. A Case of Severe Proton Pump Inhibitor-Induced Hypomagnesemia Refractory to Continuous Oral and Intravenous Magnesium Replenishment. Cureus 2024; doi: 10.7759/cureus.54483
|
| 36 |
Periklis Katopodis, Emmanouil Karteris, Konstantinos P. Katopodis. Pathophysiology of Drug-Induced Hypomagnesaemia. Drug Safety 2020; 43(9): 867 doi: 10.1007/s40264-020-00947-y
|
| 37 |
Shihming Tsai, Huiping Zhao, Bei Wu, Li Zuo, Mei Wang. Serum Magnesium Abnormality and Influencing Factors of Serum Magnesium Level in Peritoneal Dialysis Patients: A Single-Center Study in Northern China. Blood Purification 2018; 45(1-3): 110 doi: 10.1159/000485315
|
| 38 |
Shruti Gupta, Andrew Z. Fenves. The Distribution of Plasma Electrolytes. The American Journal of the Medical Sciences 2017; 354(5): 443 doi: 10.1016/j.amjms.2017.08.025
|
| 39 |
A.C.B. van Orten-Luiten, A. Janse, E. Verspoor, E.M. Brouwer-Brolsma, R.F. Witkamp. Drug use is associated with lower plasma magnesium levels in geriatric outpatients; possible clinical relevance. Clinical Nutrition 2019; 38(6): 2668 doi: 10.1016/j.clnu.2018.11.018
|
| 40 |
Andy Liu, Bellal Jubran, Emeka K. Enwere, Megan Hansen, Nicole E. Burma, Yasmin Nasser. Encyclopedia of Gastroenterology. 2020; : 18 doi: 10.1016/B978-0-12-801238-3.65617-9
|
| 41 |
Steven G. Chrysant, George S. Chrysant. Association of hypomagnesemia with cardiovascular diseases and hypertension. International Journal of Cardiology Hypertension 2019; 1: 100005 doi: 10.1016/j.ijchy.2019.100005
|
| 42 |
Stephen M. Reed, Warwick M. Bayly, Debra C. Sellon. Equine Internal Medicine. 2018; : 1029 doi: 10.1016/B978-0-323-44329-6.00016-4
|
| 43 |
Steven G Chrysant, George S Chrysant. Adverse cardiovascular and blood pressure effects of drug-induced hypomagnesemia. Expert Opinion on Drug Safety 2020; 19(1): 59 doi: 10.1080/14740338.2020.1700228
|
| 44 |
Paraish S. Misra, Sharon J. Nessim. Clinical aspects of magnesium physiology in patients on dialysis. Seminars in Dialysis 2017; 30(5): 438 doi: 10.1111/sdi.12613
|
| 45 |
Giuseppe Losurdo, Natale Lino Bruno Caccavo, Giuseppe Indellicati, Francesca Celiberto, Enzo Ierardi, Michele Barone, Alfredo Di Leo. Effect of Long-Term Proton Pump Inhibitor Use on Blood Vitamins and Minerals: A Primary Care Setting Study. Journal of Clinical Medicine 2023; 12(8): 2910 doi: 10.3390/jcm12082910
|
| 46 |
Joelle Ayoub, Nicole D. White. GERD Management. American Journal of Lifestyle Medicine 2017; 11(1): 24 doi: 10.1177/1559827616671505
|
| 47 |
Masakatsu Goto, Mari Sakai. Proton-pump inhibitor use and hyponatremia. Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics 2023; 60(2): 153 doi: 10.3143/geriatrics.60.153
|
| 48 |
Karl P. Schlingmann, Martin Konrad. Principles of Bone Biology. 2020; : 509 doi: 10.1016/B978-0-12-814841-9.00021-X
|
| 49 |
Rianne M. Douwes, António W. Gomes-Neto, Joëlle C. Schutten, Else van den Berg, Martin H. de Borst, Stefan P. Berger, Daan J. Touw, Eelko Hak, Hans Blokzijl, Gerjan Navis, Stephan J. L. Bakker. Proton-Pump Inhibitors and Hypomagnesaemia in Kidney Transplant Recipients. Journal of Clinical Medicine 2019; 8(12): 2162 doi: 10.3390/jcm8122162
|
| 50 |
Boonphiphop Boonpheng, Charat Thongprayoon, Tarun Bathini, Konika Sharma, Michael A Mao, Wisit Cheungpasitporn. Proton pump inhibitors and adverse effects in kidney transplant recipients: A meta-analysis. World Journal of Transplantation 2019; 9(2): 35-47 doi: 10.5500/wjt.v9.i2.35
|
| 51 |
Øyvind Bruserud, Bent-Are Hansen. Magnesiummangel og protonpumpehemmere. Tidsskrift for Den norske legeforening 2016; 136(16): 1336 doi: 10.4045/tidsskr.16.0620
|
| 52 |
Yoshikazu Kinoshita, Norihisa Ishimura, Shunji Ishihara. Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use. Journal of Neurogastroenterology and Motility 2018; 24(2): 182 doi: 10.5056/jnm18001
|
| 53 |
Zehra Esra Ilhan, Andrew K. Marcus, Dae-Wook Kang, Bruce E. Rittmann, Rosa Krajmalnik-Brown, Garret Suen. pH-Mediated Microbial and Metabolic Interactions in Fecal Enrichment Cultures. mSphere 2017; 2(3) doi: 10.1128/mSphere.00047-17
|
| 54 |
Jason Tan, Sonia Jeffries, Roxane Carr. A Review of Histamine-2 Receptor Antagonist and Proton Pump Inhibitor Therapy for Gastroesophageal Reflux Disease in Neonates and Infants. Pediatric Drugs 2023; 25(5): 557 doi: 10.1007/s40272-023-00580-z
|
| 55 |
Marine Perrier, Brigitte Delemer, Sophie Deguelte, Vincent Legros, Hedia Brixi, Reza Kianmanesh, Guillaume Cadiot. Total gastrectomy for severe proton pump inhibitor-induced hypomagnesemia in a MEN1/Zollinger Ellison syndrome patient. Pancreatology 2021; 21(1): 236 doi: 10.1016/j.pan.2020.12.002
|
| 56 |
Francesco Francini, Laura Gobbi, Verdiana Ravarotto, Silvia Toniazzo, Federico Nalesso, Paolo Spinella, Lorenzo A Calò. The Dietary Approach to the Treatment of the Rare Genetic Tubulopathies Gitelman’s and Bartter’s Syndromes. Nutrients 2021; 13(9): 2960 doi: 10.3390/nu13092960
|
| 57 |
Paulien Vinke, Evertine Wesselink, Wout van Orten-Luiten, Klaske van Norren. The Use of Proton Pump Inhibitors May Increase Symptoms of Muscle Function Loss in Patients with Chronic Illnesses. International Journal of Molecular Sciences 2020; 21(1): 323 doi: 10.3390/ijms21010323
|
| 58 |
Mitchell H. Rosner. Hypocalcemia in a Patient with Cancer. Clinical Journal of the American Society of Nephrology 2017; 12(4): 696 doi: 10.2215/CJN.13241216
|
| 59 |
Lingaku Lee, Irene Ramos-Alvarez, Tetsuhide Ito, Robert T. Jensen. Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome. International Journal of Molecular Sciences 2019; 20(20): 5128 doi: 10.3390/ijms20205128
|
| 60 |
Ippei Kosedo, Akihiro Tokushige, Takuro Takumi, Akiko Yoshikawa, Kiyo Teraguchi, Kenichi Takenouchi, Kouzou Shiraishi, Daisuke Ikeda, Masakazu Imamura, Takeshi Sonoda, Daisuke Kanda, Yoshiyuki Ikeda, Akio Ido, Mitsuru Ohishi. Use of proton pump inhibitors is associated with an increase in adverse cardiovascular events in patients with hemodialysis: Insight from the kids registry. European Journal of Internal Medicine 2020; 72: 79 doi: 10.1016/j.ejim.2019.11.002
|